PRESS RELEASE published on 12/22/2025 at 07:00, 7 months 18 days ago Ipsen expands early development pipeline with Simcere Zaiming’s innovative antibody drug conjugate Ipsen expands pipeline with Simcere Zaiming's novel antibody drug conjugate SIM0613 targeting LRRC15 protein for enhanced tumor penetration and anti-tumor activity. Phase I expected in H2 2026 Ipsen Antibody Drug Conjugate SIM0613 Simcere Zaiming LRRC15
BRIEF published on 12/05/2025 at 07:03, 8 months 4 days ago Transfer of Beech Tree shares to the Alasol Foundation by Ipsen Share Transfer Ipsen Henri Beaufour Beech Tree Alasol Foundation
PRESS RELEASE published on 12/05/2025 at 06:58, 8 months 4 days ago Ipsen provides update on legacy of Henri Beaufour Ipsen provides update on the transfer of Beech Tree shares to the Alasol Foundation following the passing of Henri Beaufour, Ipsen's Board Member, to support education for disadvantaged children and young adults Education Ipsen Henri Beaufour Alasol Foundation Beech Tree Shares
BRIEF published on 12/01/2025 at 07:05, 8 months 8 days ago Ipsen Announces the Passing of Henri Beaufour Business Development Board Member Ipsen Henri Beaufour Corporate Legacy
PRESS RELEASE published on 12/01/2025 at 07:00, 8 months 8 days ago Ipsen mourns the passing of Henri Beaufour, a founding family Board member Ipsen announces the passing of Henri Beaufour, a founding family Board member, with heartfelt condolences. Beech Tree and Highrock affirm support for Ipsen's future development Development Condolences Ipsen Henri Beaufour Founding Family
BRIEF published on 10/22/2025 at 07:10, 9 months 18 days ago Ipsen Reports Strong Sales and Raises 2025 Guidance Oncology Pipeline Therapeutic Areas 2025 Financial Guidance Ipsen Sales Growth ImCheck Acquisition
PRESS RELEASE published on 10/22/2025 at 07:05, 9 months 18 days ago Ipsen delivers strong sales in the first nine months of 2025 and further upgrades its full-year guidance Ipsen reports strong sales growth in first nine months of 2025, upgrades full-year guidance, and announces acquisition of ImCheck Therapeutics. Financial results and pipeline updates detailed Acquisition Sales Growth Upgrades Full-year Guidance Ipsen
PRESS RELEASE published on 10/07/2025 at 18:30, 10 months 2 days ago IPSEN - Buy-back programme - Art 5 of MAR - Week 40 - 2025
PRESS RELEASE published on 09/16/2025 at 18:30, 10 months 23 days ago IPSEN - Buy-back programme - Art 5 of MAR - Week 37 - 2025
PRESS RELEASE published on 08/19/2025 at 18:00, 11 months 21 days ago IPSEN - Buy-back programme - Art 5 of MAR - Week 33 - 2025
Published on 08/07/2026 at 23:15, 2 days 2 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 2 days 3 hours ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 2 days 3 hours ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 2 days 3 hours ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/10/2026 at 00:05, 1 hour 54 minutes ago Games of the Future Astana 2026 Comes to a Close After 12 Electric Days of Competition
Published on 08/09/2026 at 15:05, 10 hours 54 minutes ago GearUP and Escape from Tarkov Partner to Enhance Online Gaming Experience for the New Season
Published on 08/08/2026 at 16:25, 1 day 9 hours ago Bybit Sues North Korea and Lazarus Group, Secures Preliminary Injunction Freezing Stolen Assets in Landmark Crypto Asset Recovery Effort
Published on 08/07/2026 at 23:21, 2 days 2 hours ago EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 18:54, 2 days 7 hours ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 2 days 7 hours ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 17:49, 2 days 8 hours ago Crédit Agricole CIB announced the publication of the Amendment of its 2025 Universal Registration Document
Published on 08/07/2026 at 08:30, 2 days 17 hours ago Disclosure of shares outstanding and voting rights - 07.08.2026